What Actually Happens When You Stop Ozempic When you stop taking a GLP-1 medication, a few things change: Your appetite returns
Tirzepatide activates both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, whereas semaglutide targets only GLP-1
Strategies to mitigate muscle loss include: Prioritizing protein at each meal before other macronutrients Incorporating resistance training at least 23 times weekly Monitoring body composition, not just scale weight Working with your healthcare provider if side effects prevent adequate nutritionnever adjust medication doses on your own Contact your healthcare provider immediately if you experience: Severe or persistent nausea, vomiting, or abdominal pain Signs of dehydration (extreme thirst, dizziness, dark urine) Low blood sugar symptoms (if taking insulin or sulfonylureas) Inability to eat or drink for more than 24 hours Selecting appropriate protein sources is essential for patients on GLP-1 therapy, particularly given the reduced appetite and early satiety these medications produce
Furthermore, manufacturers may have been aware that gastroparesis and other serious side effects were possible
Currently, the most commonly prescribed weight loss injections in the United States include semaglutide (Wegovy, FDA-approved for weight management